Trade Cyclerion Therapeutics, Inc. - CYCN CFD

Trading Conditions

• Type: CFD
• Spread: 0.0276
• Long position overnight funding adjustment: -0.02154%
• Short position overnight funding adjustment: -0.00068%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 10
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 1.5862
• Open: 1.5062
• 1-Year Change: -43.44%
• Day's Range: 1.5062 - 1.5862

What is Cyclerion Therapeutics, Inc. (CYCN)?

Cyclerion Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery and development of therapies targeting soluble guanylate cyclase (sGC) pathways. The company focuses on addressing diseases related to cardiovascular and central nervous system disorders by leveraging its expertise in sGC modulation. Cyclerion Therapeutics engages in research and development activities to advance novel drug candidates through clinical trials. Its pipeline includes compounds aimed at conditions such as heart failure, pulmonary hypertension, and cognitive impairments. The company’s approach combines scientific innovation with a commitment to addressing unmet medical needs. Cyclerion Therapeutics operates within the biotechnology sector, collaborating with academic and industry partners to support its development programs.

Cyclerion Therapeutics, Inc. Stock Price Today: Live Overview

The price today is shaped by the latest market activity, where Cyclerion Therapeutics, Inc. maintains a price of $1.5738. Throughout the session, it has ranged from $1.5062 to $1.5862, with a daily change percentage of -1.8913%.

FAQ: Cyclerion Therapeutics, Inc. (CYCN)

What is the current price of CYCN stock?

The current price stands at $1.5738.

Does CYCN pay dividends?

No dividends are paid by the company.

Does CYCN have a formal corporate presence or regional headquarters in the UAE?

Cyclerion Therapeutics, Inc. does not have an official office or subsidiary in the UAE and operates via partners only.

What is CYCN best known for?

Cyclerion Therapeutics, Inc. is most famous for its development of therapies targeting soluble guanylate cyclase.

What assets are typically shown together with CYCN?

Commonly shown alongside CYCN: Hysan Dev, Liberty Broadband, Rigetti Computing, Inc.